Read about Trishna Bharadia’s experiences with patient collaborations. What has been the impact of COVID-19, and how does she see the future of patient partnerships?
Publication Lead Chris Brooks discusses the impact of COVID-19 on medical communications.
Overcoming scientific communication challenges during COVID-19: insights from a Global Publications Director
Read Lucy Turner’s perspective on the impact of COVID-19 on medical publications and congresses.
Read Becca Wilson’s perspectives on the current reality and future opportunities for disability inclusivity in medical research and communications.
Combatting research integrity breaches: insights from Suzanne Farley, Director of the Springer Nature Research Integrity Group
Read Suzanne Farley’s perspectives on the steps one publisher is taking to address the growing problem of research misconduct.
Read Ivan Oransky’s take on the retraction landscape and his perspectives on how to tackle research integrity issues in the future.
Data sharing is crucial for reproducibility. Iain Hrynaszkiewicz shares his thoughts on how publishers can promote its uptake.
Overcoming barriers to reporting negative data: perspectives from the Center for Biomedical Research Transparency’s founder
Sandra Petty discusses the Null Hypothesis Initiative and looks to the future of reporting negative data.
Professor Marcus Munafò discusses the importance of reproducibility in scientific research and how we can overcome barriers to achieving it.
Scientist-turned-filmmaker Randy Olson points to narrative structure as the essential element for clarity and increased audience engagement in scientific communication.
How research can be shared effectively to advance science: insights from the Center for Open Science
David Mellor from the Center for Open Science explains how the company is supporting and facilitating the open science movement.
Slávka Baróniková shares her opinions on open access publishing and suggests how this can be successfully achieved within pharma.
What is the optimal design for a scientific poster? Insights from the founder of the #betterposter movement
Mike Morrison discusses the problem with traditional scientific posters and how they could be redesigned to more effectively communicate research.
Jackie Marchington gives her perspective on the Good Practice for Conference Abstracts and Presentations (GPCAP) recommendations.
Dawn Lobban, Senior Scientific Lead at Alligent Europe, Envision Pharma shares her experience of involving patients in medical publishing.
Caroline Halford, Digital Publishing Manager at Springer Healthcare, gives her view on the value of enhanced features and an update on the evolution of digital publishing.